Ohlstein EH - Search Results

1

Endotoxin-mediated changes in plasma endothelin concentrations, renal endothelin receptor and renal function.

Nambi P, Pullen M, Slivjak MJ, Ohlstein EH, Storer B, Smith EF 3rd. Nambi P, et al. Among authors: ohlstein eh. Pharmacology. 1994 Mar;48(3):147-56. doi: 10.1159/000139174. Pharmacology. 1994. PMID: 8153142

2

Further characterization of the cardiovascular effects of the dopamine beta-hydroxylase inhibitor SK&F 102698 in conscious hypertensive rats.

Ohlstein EH, Kruse LI, Ezekiel M, Willette RN. Ohlstein EH, et al. J Pharmacol Exp Ther. 1988 Oct;247(1):186-95. J Pharmacol Exp Ther. 1988. PMID: 3050029

3

Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade.

Ohlstein EH, Brooks DP, Feuerstein GZ, Ruffolo RR Jr. Ohlstein EH, et al. Pharmacology. 1997 Nov;55(5):244-51. doi: 10.1159/000139534. Pharmacology. 1997. PMID: 9399334

4

Functional evidence that balloon angioplasty results in transient nitric oxide synthase induction.

Douglas SA, Vickery-Clark LM, Ohlstein EH. Douglas SA, et al. Among authors: ohlstein eh. Eur J Pharmacol. 1994 Apr 1;255(1-3):81-9. doi: 10.1016/0014-2999(94)90085-x. Eur J Pharmacol. 1994. PMID: 7517884

5

Relationship between LTD4-induced endothelium-dependent vasomotor relaxation and cGMP.

Secrest RJ, Ohlstein EH, Chapnick BM. Secrest RJ, et al. Among authors: ohlstein eh. J Pharmacol Exp Ther. 1988 Apr;245(1):47-52. J Pharmacol Exp Ther. 1988. PMID: 2834545

6

Combination of the thromboxane receptor antagonist, sulotroban (BM 13.177; SK&F 95587), with streptokinase: demonstration of thrombolytic synergy.

Kopia GA, Kopaciewicz LJ, Ohlstein EH, Horohonich S, Storer BL, Shebuski RJ. Kopia GA, et al. Among authors: ohlstein eh. J Pharmacol Exp Ther. 1989 Sep;250(3):887-95. J Pharmacol Exp Ther. 1989. PMID: 2528630

7

Localization and characterization of alpha-2 adrenoceptors in the isolated canine pulmonary vein.

Ohlstein EH, Horohonich S, Shebuski RJ, Ruffolo RR Jr. Ohlstein EH, et al. J Pharmacol Exp Ther. 1989 Jan;248(1):233-9. J Pharmacol Exp Ther. 1989. PMID: 2536428

8

In vivo imaging of cardiovascular endothelin receptors using the novel radiolabelled antagonist [18F]-SB209670 and positron emission tomography (microPET).

Johnström P, Fryer TD, Richards HK, Barret O, Clark JC, Ohlstein EH, Pickard JD, Davenport AP. Johnström P, et al. Among authors: ohlstein eh. J Cardiovasc Pharmacol. 2004 Nov;44 Suppl 1:S34-8. doi: 10.1097/01.fjc.0000166217.27544.6b. J Cardiovasc Pharmacol. 2004. PMID: 15838315

9

Monocyte chemoattractant protein-1 is upregulated in rats with volume-overload congestive heart failure.

Behr TM, Wang X, Aiyar N, Coatney RW, Li X, Koster P, Angermann CE, Ohlstein E, Feuerstein GZ, Winaver J. Behr TM, et al. Circulation. 2000 Sep 12;102(11):1315-22. doi: 10.1161/01.cir.102.11.1315. Circulation. 2000. PMID: 10982549

10

Expression of human preproendothelin-1 cDNA in COS cells results in the production of mature vasoactive endothelin-1.

DiLella AG, Ohlstein E, Elshourbagy N, Bhatnagar PK, Nambi P, DeWolf WE Jr, Caltabiano MM. DiLella AG, et al. Biochem Biophys Res Commun. 1991 Mar 15;175(2):697-705. doi: 10.1016/0006-291x(91)91622-j. Biochem Biophys Res Commun. 1991. PMID: 2018512

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results